°ê¥ß¶§©ú¤j¾Ç¥Íª«ÃľǬã¨s©Ò
¤E¤Q¤E¾Ç¦~«×´»´Á±À¼s±Ð¨|¾Ç¤À¯Z
| ¬ì¥Ø¦WºÙ |
¾Ç¤À¼Æ |
±Ð®v©m¦W |
¶}½Ò®É¶¡/±Ð«Ç |
¹wp©Û¥Í¼Æ |
|
1 |
Ĭ Þ·¡B ªL½«¹t |
99.6.28~99.7.14 ¥ÍÃĩҤ@¼Ó¶¥±è±Ð«Ç |
40¤H |
|
|
1 |
¬_¶¶Às |
99.6.29~97.7.22 ¥ÍÃĩҤ@¼Ó¶¥±è±Ð«Ç |
40¤H |
|
|
1 |
§dºaÀé |
99.7.16~99.7.30 ¥ÍÃĩҤ@¼Ó¶¥±è±Ð«Ç |
40¤H |
¡»¤W½Ò¦aÂI¡G¶§©ú¤j¾Ç¥Íª«ÃľǩҤ@¼Ó¶¥±è±Ð«Ç
¡]¥x¥_¥«¥ß¹Aµó¤G¬q155¸¹¡A¥i·f¼±¶¹B²H¤ô½u©ó¥ÛµP¯¸¤U¨®¡A¦A¨B¦æ¬ù¤Q~¤Q¤¤ÀÄÁ¡^
¡»©Û¥Í¹ï¶H¡G
1. ¦U¤½¨p¥ß¤j±M°|®Õ¬ÛÃö¾Ç¨t¤j¾Ç³¡¾Ç¥Í¤Î¬ã¨s¥Í¡C
2. ¦U¤½¨p¥ß°ê¤¤¡B°ª¤¤¥H¤W¾Ç®Õ¤§¬ÛÃö±Ð®v¡C
3. ¥Íª«¬ì§Þ¬ÛÃö²£·~¬É¤H¤h¡C
¡»½Òµ{²¤¶¡G½Òµ{ªí¤U¸ü¡A¦ý¥H´»´Á¹ê»Ú½Òµ{¬°·Ç¡C
¡»¾Ç ¶O¡G
|
¾Çû¨¥÷ |
®Õ¥~¬ã¨s¥Í¡B |
¶§©ú¤j¾Ç¤j¾Ç³¡¾Ç¥Í¡BºÓ³Õ¤h¬ã¨s¥Í(§t99¾Ç¦~¤J¾Ç¤§·s¥Í) |
®Õ¥~¤j¾Ç¥Í |
²£·~¬É¤H¤h |
|
¾Ç¤À¶O(¨C¾Ç¤À) |
1,560¤¸ |
§K¦¬¾Ç¤À¶O |
1,100¤¸ |
3,000¤¸¡C |
(1)®Õ¥~¤H¤h±ÄÀH¯ZªþŪ¤è¦¡¡A¦ý¦¬¶O¤è¦¡¨Ì±À¼s¾Ç¤À¯Z¾Ç¤À¶O(¤W¤è©Ò¦C¾Ç¶O¹ï¶H¤Î¦¬¶O¼Ð·Ç)pºâ¡C
(2)¶§©ú¤j¾Ç¤j¾Ç³¡¾Ç¥Í¡BºÓ³Õ¤h¬ã¨s¥Í§K¦¬¾Ç¤À¶O¡C
(3)³Ì¨ä¤¤ÃĪ«¶}µoªº·sÁͶլ°¥»©Ò»PÃIJz©Ò¦X¶}¡C¬ã¨s¥Í(ºÓ¡B³Õ¤h¥Í)¤Î¨ä¥L²£·~©ÎªÀ·|¤H¤h(«D¤j¾Ç¥Í)½Ð¦ÜÃIJz©Ò³ø¦W¡Chttp://gpp.ym.edu.tw/ndhm/leca2/index.asp
¤j¾Ç³¡¾Ç¥Í(®Õ¤º¡B¥~®Õ)Åwªï¦Ü¥»©Ò³ø¦W¡C
¡»³ø¦W¤è¦¡¡G
(1)½Ð¥H½u¤W³ø¦W¤è¦¡¡A±N³ø¦Wªí¥H¹q¤l¶l¥ó±H¦Ü¡Gbps@ym.edu.tw
¡]¼Ð©ú´»´Á¾Ç¤À¯Z³ø¦W¡^
(2)³ø¦W´Á¶¡¡G§Y¤é°_¦Ü
(3)Ápµ¸¤è¦¡¡G 02-2826-7000 # 5604
(4)³Ì·s°T®§½Ð°Ñ¦Ò¶§©ú¤j¾Ç¥Íª«ÃľǩҺô¯¸¡Ahttp://www.ym.edu.tw/bps/
¡»¿ý¨ú¤Î³ø¨ì¡G
¢°¡B
¿ý¨ú³qª¾¡G
¥Íª«ÃľǩҺô¯¸¡Ahttp://www.ym.edu.tw/bps/
¢±¡B
³ø¨ì¤è¦¡¡G¿ý¨úªÌ»Ý©ó
¢²¡B
ú¶O¤è¦¡¡G
6¤ë25¤é«e¥H²{ª÷¥æµ¹
°ê¥ß¶§©ú¤j¾Ç¡A¨Ã³s¦P³ø¦Wªí±H¦Ü¥x¥_¥«¥ß¹Aµó¤G¬q155¸¹¡A¶§©ú¤j¾Ç¥ÍÃĩҴ»´Á¾Ç¤À¯Z ¦¬¡C
¡»¾Ç¤ÀÃÒ©ú¡G
(1) ¤W½Ò´Á¶¡¡A¥X®u²v¶W¹L(§t)80%¡A¥B¦Ò¸Õ¦¨ÁZ¦X®æªÌ¡A¥Ñ¶§©ú¤j¾Ç±Â¤©¾Ç¤ÀÃÒ©ú¡C
(2) ¥»®Õ¾Ç¥ÍÀ³©ó×Ū¥»¾Ç¤À¯Z¤§·í¾Ç´Á¦V¶}¿ì³æ¦ì½T»{¬O§_±Äp¾Ç¤À¦¨ÁZ¡A¶}¯Z·í¾Ç´Á¥¼½T»{ªÌ¡A¤é«á¤£±on¨D±Äp¦¨ÁZ¡A¶È±o¾Ì¦U¯Z¦¸¦¨ÁZ³æ©Î¾Ç¤ÀÃÒ©ú®Ñ¥Ó½Ð¾Ç¤À©è§K¡C
(3) ¥»®Õ¾Ç¥Í×Ū¥»¾Ç¤À¯Z½Òµ{¤§¥[°h¿ï½Ò©ó¿ï½Ò¨t²Î¤¤¤£¤©³B²z¡A¥t©ó¥[°h¿ï«á¥Ñ¥»¾Ç¤À¯Z±N½T»{¦Cp¬°¥»®Õ²¦·~¾Ç¤À¤Î¦¨ÁZ¤§¦W¥U¡A·J¾ã°e½Ò°È²Õ¿ì²z¾Ç¤Àµn¿ý¨Æ©y¡C
(4)®Õ¥~¾Çûײ¦¥»½Òµ{¡A¥B¦Ò¸Õ¦¨ÁZ¤Î®æªÌ¡A¥Ñ¥»®Õµoµ¹¾Ç¤ÀÃÒ©ú®Ñ¡C
ªþµù¡Gƒx¥H¤W½Òµ{±N¦b¥Íª«ÃľǬã¨s©Ò³W¹º¹êÅç«Ç¶i¦æ±Ð¾Ç¡C
(ªþ¥ó¤@) 99¦~«×ÀÀ¶}³]¤§½Òµ{(¤£§t¹ê²ß½Òµ{) (¨C¤@½Òµ{¤@¶)
1.½Òµ{°ò¥»¸ê®Æ¡G
|
½Òµ{¦WºÙ |
¶}½Ò¾Ç´Á |
¥²×/¿ïס@ |
¹w¦ô×½Ò¤H¼Æ |
||
|
¦yºÝ¥Íª«§Þ³N¦b¥Í§Þ·sÃĶ}µoªºÀ³¥Î |
¡¼¤W¾Ç´Á ¡¼¤U¾Ç´Á ùþ´»´Á |
¡¼¥²× ¡½¿ï× |
40 |
||
|
t³d¦Ñ®v |
¾Ç¤À¼Æ |
¹ê»Ú±Â½Ò®É¼Æ |
¤W½Ò®É¶¡ |
||
|
Ĭ Þ·¡BªL½«¹t |
1 |
18 |
06/28-07/14¡A¨C¶g¤@¤T¤ |
||
2.½Òµ{±Â½Ò¤jºõ¤Î¤º®e¡i¤é´Á¡BÃD¥Ø¡B±Â½Ò¦Ñ®v(½Ðµù©ú®Õ¤º¡B®Õ¥~©Î²£·~¬É)¤Î¤W½Ò®É¼Æ¡j¡G
|
¤é´Á |
Á¿ÃD |
®É¼Æ |
±Â½Ò¦Ñ®v |
|
06/28 |
Production of recombinant protein
therapeutics in micro-organism |
1 |
¬_¶¶Às |
|
06/28 |
Production of
recombinant protein therapeutics in cultivated mammalian cells |
1 |
¬_¶¶Às |
|
06/30 |
The past,
present and future of cell-free protein synthesis |
1 |
ªL½«¹t |
|
06/30 |
Protein folding and misfolding |
1 |
ªL½«¹t |
|
07/05 |
Protein drug
stability: a formulation challenge |
1 |
§dºaÀé |
| 07/05 |
Bioeqivalence and the
immunogenicity of biopharmaceuticals |
1 |
§dºaÀé |
|
07/05 |
Protein
microarray technology |
1 |
ªL·Ó¶¯ |
|
07/05 |
Mass spectrometry-based proteomics |
1 |
ªL·Ó¶¯ |
|
07/07 |
Engineering
plants with increased disease resistance and as factories for
biopharmaceuticals |
1 |
ªL½«¹t |
|
07/07 |
Genetic microsatellite
markers in plants |
1 |
ªL½«¹t |
|
07/09 |
Mating antibody
phage display with proteomics |
1 |
¬_¶¶Às |
|
07/09 |
Production of
human monoclonal antibody in eggs of chimeric chickens and transgenic animals |
1 |
¬_¶¶Às |
|
07/12 |
Designing
combinatorial libraries for drug discovery |
1 |
¿½±RÞ³ |
|
07/12 |
Chemical
database techniques in drug discovery |
1 |
¿½±RÞ³ |
|
07/14 |
Molecular
imaging in drug discovery and development |
1 |
Ĭ޷ |
|
07/14 |
In vivo imaging of
gene delivery and expression |
1 |
Ĭ޷ |
|
½Òµ{¦WºÙ |
¶}½Ò¾Ç´Á |
¥²×/¿ïס@ |
¹w¦ô×½Ò¤H¼Æ |
||
|
ÃĪ«¶}µoªº·sÁÍ¶Õ |
¡¼¤W¾Ç´Á ¡¼¤U¾Ç´Á ùþ´»´Á |
¡¼¥²× ùþ¿ï× |
40 |
||
|
t³d¦Ñ®v |
¾Ç¤À¼Æ |
¹ê»Ú±Â½Ò®É¼Æ |
¤W½Ò®É¶¡ |
||
|
¬_¶¶Às, ¿½±RÞ³ |
1 |
18 |
06/29-07/22¡A¨C©P¤G¡B¥| |
||
2.½Òµ{±Â½Ò¤jºõ¤Î¤º®e¡i¤é´Á¡B¹ê²ß¤º®e¡B±Â½Ò¦Ñ®v(½Ðµù©ú®Õ¤º¡B®Õ¥~©Î²£·~¬É)¤Î¤W½Ò®É¼Æ¡j¡G
|
¤é´Á |
Á¿ÃD |
®É¼Æ |
±Â½Ò¦Ñ®v¡]½Ðµù©ú®Õ¤º©Î¥L®Õ©Î²£·~¬É¤H¤h¡^ |
|
06/29 |
¶Ç¬V¯fªº¦º¤`«Â¯Ù ¡V ·L¥Íª«¥@¬Éªº¾¤©ú |
1 |
§dºaÀé (®Õ¤º) |
|
|
¤Æ¾ÇÀøªkªºÀÆ¥ú ¡V 606 ªº¦¨¥\ |
1 |
§dºaÀé (®Õ¤º) |
|
07/01 |
½L¥§¦èªLªº½Ï¥Í --- §Ü¥Í¯À¥@¬Éªº¶}®i |
1 |
¿½±RÞ³ (®Õ¤º) |
|
|
µ²®Öµßªº¹¥ªA»P¦º¦Ç´_¿U --- §ÜÃĩʪº¾÷¨î |
1 |
¿½±RÞ³ (®Õ¤º) |
|
07/06 |
²üº¸»X¤ÎÃþ©T¾J |
1 |
¬_¶¶Às (®Õ¤º) |
|
|
´Óª«ÃĪº©l¯ª¾~¤ù --- ¶Ü°Øªº¥\»P¹L |
1 |
¬_¶¶Às (®Õ¤º)
|
|
07/08 |
±qªü´µ¤ÇÆF¶}©lªº§Üµoª¢ÃĪ«ªºµo®i |
1 |
Ĭ Þ· (®Õ¤º) |
|
|
¥¢¯v»P¼~Æ{ºë¯«ÃĪ« |
1 |
Ĭ Þ· (®Õ¤º) |
|
07/13 |
¯f¬r¥@¬É»P¬Ì]µo®i |
1 |
¬_¶¶Às (®Õ¤º) |
|
|
³æ®è§ÜÅ骺·s¬D¾Ô |
1 |
¬_¶¶Às (®Õ¤º) |
|
07/15 |
RNA interference ªº·s®i±æ |
1 |
¬_¶¶Às (®Õ¤º) |
|
|
°ò¦]»P·F²ÓMªvÀøªº®i¶} |
1 |
¬_¶¶Às (®Õ¤º) |
|
07/20 |
³J¥ÕÃĪ«ªº·s¬ö¤¸ |
1 |
ªL½«¹t (®Õ¤º) |
|
|
Apatmer ÃĪ«ªº³Ì·s¶i®i |
1 |
ªL½«¹t (®Õ¤º) |
|
07/22 |
ªeª¼¯g±q¦a²y¤W®ø¥¢-§Ü±H¥ÍÂÎÃĪº¥@¬ö¤jµo²{ |
1 |
§dºaÀé (®Õ¤º) |
|
|
Àù¯fªº¹ÚÅä --- ÃĪ«¶}µoªº·¥ ? |
1 |
§dºaÀé (®Õ¤º) |
|
½Òµ{¦WºÙ |
¶}½Ò¾Ç´Á |
¥²×/¿ïס@ |
¹w¦ô×½Ò¤H¼Æ |
||
|
¤¤¦è¤ñ¸ûÃIJz¾Ç |
¡¼¤W¾Ç´Á ¡¼¤U¾Ç´Á ùþ´»´Á |
¡¼¥²× ùþ¿ï× |
40 |
||
|
t³d¦Ñ®v |
¾Ç¤À¼Æ |
¹ê»Ú±Â½Ò®É¼Æ |
¤W½Ò®É¶¡ |
||
|
§dºaÀé |
1 |
18 |
07/16-07/30 |
||
2.½Òµ{±Â½Ò¤jºõ¤Î¤º®e¡i¤é´Á¡B¹ê²ß¤º®e¡B±Â½Ò¦Ñ®v(½Ðµù©ú®Õ¤º¡B®Õ¥~©Î²£·~¬É)¤Î¤W½Ò®É¼Æ¡j¡G
|
¤é´Á |
Á¿ÃD |
®É¼Æ |
±Â½Ò¦Ñ®v¡]½Ðµù©ú®Õ¤º©Î¥L®Õ©Î²£·~¬É¤H¤h¡^ |
|
07/16 |
ÆFªÛªº°g¥¢: ªø¥Í¤£¦Ñªº¬D¾Ô |
1 |
§dºaÀé (®Õ¤º) |
|
|
¤H᪺ÃÄ®Ä: ¥j¤µ¤¤¥~¤§Á¼ |
1 |
§dºaÀé (®Õ¤º) |
|
07/19 |
»È§öªº¥@¬É: °ê»Ú´Óª«Ãĵo®iªº¨å½d |
1 |
§dºaÀé (®Õ¤º) |
|
|
¶À³s°¨x¤õªº¬ì¾Ç¸ÑªR: ²{¥NÂå¾Çªº·s¬D¾Ô |
1 |
§dºaÀé (®Õ¤º) |
|
07/21 |
¬õÄT»P Lovastatin : ¤¤¦èÃĪº¥æ·|»P¨M¾Ô |
1 |
§dºaÀé (®Õ¤º) |
|
|
¥VÂήL¯óªº¯u¹ê»P¹Ú¤Û |
1 |
§dºaÀé (®Õ¤º) |
|
07/23 |
¤sÃįqµÇ±j¸y¸}: °©½è²¨ÃP¯gªºÀø®Ä¶}µo |
1 |
§dºaÀé (®Õ¤º) |
|
|
¤Ñªá¯»³J¥Õ: ª¢¶À¤l®]ªºÅº¶Æ ! |
1 |
§dºaÀé (®Õ¤º) |
|
07/26 |
¦óº¯Q¸É¨x¯q¦åªº²{¥N¬ã¨s |
1 |
§dºaÀé (®Õ¤º) |
|
|
¤ÆF¯×¬¡¦å¤Æ·ïÀø®Äªº§ÜÀùÃĪ«¶}µo |
1 |
§dºaÀé (®Õ¤º) |
|
07/27 |
³e¸³s¼ (St. John's Wort) §Ü§íÆ{°ò¦¬ã¨s»PÁ{§ÉÀø®Ä¸ÑªR |
1 |
§dºaÀé (®Õ¤º) |
|
|
Á¤¶Àªº¤¤¦èÃIJz¾Ç¤ÎÀø®ÄµûªR |
1 |
§dºaÀé (®Õ¤º) |
|
07/29 |
·íÂkªº¤¤¦èÃIJz¬ã¨s¸ÑªR |
1 |
§dºaÀé (®Õ¤º) |
|
|
®ãJªº¤¤¦è¤ñ¸ûÃIJz¾Ç¬ã¨s |
1 |
§dºaÀé (®Õ¤º) |
|
07/30 |
§Ü±H¥ÍÂÎÃÄ«C»U¤Î®ü¤H¯ó¶}µo |
1 |
§dºaÀé (®Õ¤º) |
¡»¤U¸ü½Òªí
¡»¤E¤Q¤E¾Ç¦~«×±À¼s±Ð¨|¾Ç¤À¯Z³ø¦W¤U¸ü³ø¦Wªí